Ischemic cardiomyopathy and heart failure after acute myocardial infarction
Abstract Purpose of Review Ischemic cardiomyopathy refers to systolic left ventricular
dysfunction in the setting of obstructive coronary artery disease and represents the most …
dysfunction in the setting of obstructive coronary artery disease and represents the most …
[HTML][HTML] Where Are We With Treatment and Prevention of Heart Failure in Patients Post–Myocardial Infarction?
J Carberry, G Marquis-Gravel, E O'Meara… - JACC: Heart Failure, 2024 - Elsevier
As a result of the widespread use of reperfusion therapies and secondary prevention over
the last 30 years, there has been a dramatic reduction in the risk of mortality and …
the last 30 years, there has been a dramatic reduction in the risk of mortality and …
Heart failure after ST-elevation myocardial infarction: beyond left ventricular adverse remodeling
MG Del Buono, CM Garmendia, IM Seropian… - Current problems in …, 2023 - Elsevier
ST-segment elevation myocardial infarction (STEMI) remains a significant source of
morbidity and mortality worldwide. Despite advances in treatment leading to a significant …
morbidity and mortality worldwide. Despite advances in treatment leading to a significant …
Treatment of asymptomatic left ventricular dysfunction
GV Moukarbel, SD Solomon - Current treatment options in cardiovascular …, 2008 - Springer
Opinion statement Patients with abnormalities of left ventricular (LV) systolic or diastolic
function may have no symptoms, especially in the early stages. These patients are not …
function may have no symptoms, especially in the early stages. These patients are not …
New and emerging pharmacological strategies in the management of chronic heart failure
H Krum - Current opinion in Pharmacology, 2001 - Elsevier
Chronic heart failure is a complex syndrome involving the activation of multiple cellular,
metabolic and neurohumoral pathways following the initial myocardial insult. Because of the …
metabolic and neurohumoral pathways following the initial myocardial insult. Because of the …
Long-term pharmacological management of reduced ejection fraction following acute myocardial infarction: Current status and future prospects
AAI Abel, AL Clark - International Journal of General Medicine, 2021 - Taylor & Francis
Heart failure (HF) with reduced ejection fraction is common following acute myocardial
infarction (MI), and active medical management can have a profound impact on prognosis …
infarction (MI), and active medical management can have a profound impact on prognosis …
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction
• The industry-sponsored, international, multicenter, randomized, double-blind, active-
comparator trial, PARADISE-MI 1 (Prospective ARNI vs. ACE Inhibitor Trial to Determine …
comparator trial, PARADISE-MI 1 (Prospective ARNI vs. ACE Inhibitor Trial to Determine …
Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction: a review
Importance Despite advances in cardiac care, patients remain at a high risk of death and the
development of heart failure (HF) following myocardial infarction (MI). These risks are …
development of heart failure (HF) following myocardial infarction (MI). These risks are …
[引用][C] LV dysfunction and heart failure following myocardial infarction
RD Patten, JE Udelson, MA Konstam - Heart Failure Management, 2000
Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure
J Tamargo, J López-Sendón - Revista Española de Cardiología (English …, 2004 - Elsevier
Congestive heart failure is a leading cause of cardiovascular morbidity and mortality, and is
the main cause of hospitalization among patients older than 65 years. Moreover, its …
the main cause of hospitalization among patients older than 65 years. Moreover, its …